Navigation Links
Penn researchers discover 'modus operandi' of heart muscle protein
Date:4/10/2008

PHILADELPHIA Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called leiomodin (Lmod) promotes the assembly of an important heart muscle protein called actin. Whats more, Lmod directs the assembly of actin to form the pumping unit of the heart. The findings appear in this weeks issue of Science.

Very little was known about Lmod when we began this study, says lead author Roberto Dominguez, PhD, Associate Professor of Physiology.

It appeared that this protein was present in muscle cells but this had not been demonstrated directly and nobody knew what it did, explains Dominguez. We compared the amino acid sequence of Lmod with the sequence of another protein called tropomodulin [Tmod] that was already known to bind actin filaments in muscle cells. We found that one part of Lmod was very similar to Tmod, but Lmod was a bigger protein than Tmod and contained unique features that made us suspect that it could assemble the actin filaments of the heart muscle. This is exactly what we found.

The results answer a question that scientists studying the heart have long asked: What controls the assembly of the pumping unit of the heart?

Actin is the most abundant protein in most animal cells and forms long polymers, or filaments, that make up the cell skeleton. In the cells that make up muscles and the heart, interactions of actin filaments with motor proteins produce the contractions that pump blood through the body.

Actin spontaneously forms polymers in test tubes, but living cells use nucleator proteins to control the time and place where actin filaments forms. For a long time, physiologists have wondered what serves as the nucleator protein in cardiac muscle cells, says co-author Professor Thomas Pollard, PhD, of Yale University. It was very satisfying after all these years to discover that Lmod can serve as the nucleator protein to initiate the forming of actin polymers in hear
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers Pursuing Nasal Anthrax Vaccine
2. Researchers find mass media campaigns useful
3. Researchers pilot new electronic system for infectious illness
4. Researchers Find Gene Mutation That Increases Asthma Risk
5. Researchers Define Mechanism of Methamphetamine Addiction
6. Attacks against medical researchers: Time to take a stand
7. Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation
8. More genes for Lou Gehrigs disease identified, according to Penn researchers
9. Clinical trial volunteers mostly indifferent -- but not blind to -- researchers financial conflicts
10. Researchers learn how signaling molecule orchestrates breast cancers spread
11. Researchers ID gene linked to lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... ... a Balloon Sinuplasty website to inform potential Nashville area sinus sufferers ... can be used to determine if someone is a good candidate for Balloon ...
(Date:7/30/2015)... ... July 31, 2015 , ... Reduce Human Error ... **Presented by FDAnews and Ginette M. Collazo, Inc.**, Sept. 16-17, 2015 – Raleigh, ... helping drug, biologic and device firms reduce manufacturing errors by 50 percent or ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... announces I am Fine, an app invention that can help people during emergencies. ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Currently, there ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide the twenty ... making a change in his practice. , The decision will also allow him to ... Aggarwal will be transferring his in-patient admissions to the hospitalists at East Liverpool City ...
(Date:7/30/2015)... ... 30, 2015 , ... In a meaningful ritual intended to symbolize a final ... Center have created an addiction graveyard. Sharing this with the public comes at a ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he moved ...
Breaking Medicine News(10 mins):Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 2Health News:Nashville Otolaryngologist Dr. David Gilpin Launches Balloon Sinuplasty Website 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 2Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 3Health News:FDAnews Announces — Reduce Human Error on the Drug and Device Manufacturing Floor: Reduce Errors By 50% or More Workshop, Sept. 16-17, 2015 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3
... about memory could offer an early warning system for ... at Rush University Medical Center. The researchers have found// ... changes in the brain related to Alzheimer's disease. Their ... Neurology. ,The researchers looked at the association ...
... issued on Dec 1 (World AIDS Day), more than 3 ... to// HIV and million jobs a year are lost due ... crippling effect on the workforce of many countries. ... the future working generations – the report said. The ILO ...
... time of vaccination may reduce the effectiveness of the vaccine, ... the goal is to produce as many antibodies as possible ... ,To do this, white blood cells (B cells) that ... body against infections spring into action to produce the antibodies. ...
... that GPs earnings average around ?106,000 in the initial ... Centre for health and social care depict an increase ... 2004-05. ,Ministers and NHS Bigwigs are mighty ... instead of pumping them for improving the quality of ...
... in the news for the wrong reasons and now scientists ... agent of the side-//effects. The answer hovers around the vital ... scientists reveal., ,These drugs known as COX-2 inhibitors ... like arthritis. The drugs achieve its purpose by hampering the ...
... Canada has informed Swiss Pharmaceutical Roche AG to include ... influenza drug, Tami flu. This advice is close// on ... the drug, sparking erratic behaviors, hallucination and even inducing ... teens in Japan. , ,According to a statement ...
Cached Medicine News:Health News:Memory Complaints Are Associated With Alzheimer's Disease 2Health News:Memory Complaints Are Associated With Alzheimer's Disease 3Health News:ILO Reports On The Crippling Effects Of HIV On The Workforce 2
(Date:7/30/2015)... July 30, 2015   Sentrian , the ... preventable hospitalization, recently received confirmation from the Food ... Intelligence (RPI) solution meets the definition of a ... exercise "Enforcement Discretion." The designation ... further FDA regulatory requirements at this time" and ...
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
(Date:7/30/2015)... Company, Inc. (NYSE: LCI ) today announced that ... Annual Growth Conference on Wednesday, August 12, 2015, at ... A webcast of the presentation will be ... visit the web site at least 10 minutes prior ... and install any necessary software.  The presentation will be ...
Breaking Medicine Technology:FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ... develops and commercializes prescription,drugs for the treatment ... announced that it has begun enrollment for ... trial evaluating,CPP-109 for the treatment of patients ...
... Company,s End-of-Phase II Meeting with FDA Set for ... TorreyPines Therapeutics,Inc. (Nasdaq: TPTX ) today ... Meeting of the American Headache Society showed that, ... pain relief at two,hours, the company,s lead AMPA/kainate-type ...
Cached Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 2Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 3Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction 4Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 2Data Presented at American Headache Society's Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics' Tezampanel 3
... Continuing a tradition of progressive centrifuge ... CL3 series. The Centra-CL3 and Centra-CL3R (refrigerated) ... todays laboratory., Quality Control Over Sample ... and lock up to 99 protocols and ...
Inquire...
... Rotor has a standard 1.5ml rotor and 6 ... Easy operation (no switches to mess with). Simply ... the plastic tab to open. Starts and stops ... 2000 x g. Only five inches in diameter. ...
Inquire...
Medicine Products: